Target intelligence / Profile preview

Envelope Glycoprotein 120 (gp120)

Target
gp120
Molecular classification
Glycoprotein, Viral Envelope Protein
01

Overview

Envelope glycoprotein 120 (gp120) is a surface-exposed glycoprotein of the Human Immunodeficiency Virus (HIV), essential for viral entry into host cells. It is part of the envelope spike complex, which also includes gp41, and plays a central role in virus attachment and membrane fusion. Gp120 mediates HIV entry through sequential interactions: binding to CD4 receptors, followed by CCR5/CXCR4 coreceptors, triggering membrane fusion. It is a highly immunogenic but variable protein, targeted for vaccine development and antiviral therapies.

Other names
HIV gp120Env gp120Glycoprotein 120
02

Mechanism of action

Small-molecule inhibitors targeting entry steps are under investigation.

03

Biological functions

Viral entryCD4 receptor bindingCCR5/CXCR4 coreceptor bindingMembrane fusionImmune evasion
04

Disease associations

HIV infectionAIDS
05

Safety considerations

High variability due to rapid mutation rates complicating vaccine designGlycan shield masking key epitopes from neutralizing antibodies

Beyond the preview

Go deeper on Envelope Glycoprotein 120 (gp120).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Envelope Glycoprotein 120 (gp120).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call